OClawVPS.com
BioHarvest Sciences
Edit

BioHarvest Sciences

http://www.bioharvest.com/
Last activity: 20.12.2024
Active
Categories: BioTechEngineeringGrowthITPlatformProductResearchScienceTechnologyWellness
BioHarvest Sciences produces and sells a food-based nutraceutical product called ViniaTM which contains the whole range of piceid resveratrol in natural state. The product is made by growing plant cells from red grapes in bioreactors utilizing the Issuer’s platform technology which allows the growing of specific cells instead of the whole plant. The Issuer is also completing research to adapt its platform technology to growing of cannabis cells under a cannabis research license in Israel.
Likes
273
Followers
1.49K
Website visits
6.8K /mo.
Mentions
36
Location: Canada, British Columbia, Vancouver
Employees: 201-500
Phone: +1 604-622-1186
Founded date: 2018

Investors 1

Mentions in press and media 36

DateTitleDescription
20.12.2024Ingredients Giant Tate & Lyle Strikes Deal to Develop Next-Gen Plant-Based Sweeteners4 Mins Read Tate & Lyle has collaborated with BioHarvest Sciences to develop plant-based sweeteners that are better for human and planetary health. British ingredients giant Tate & Lyle – which manufactures the sugar substitute Sple...
10.02.2022BioHarvest Sciences Inc. Engages Thunder11 as a Public Relations Agency of RecordVancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 10, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTC PINK: CNVCF) (FSE:8MV) ("BioHarvest" or "the Company") a fast-growing Biotech firm listed ...
26.01.2022BioHarvest Sciences Inc. Projects 2022 Revenue to Grow 2.5X-3.5X to a Range of USD $5M-$7M2022 Revenue will include sales of VINIA® and Cannabis, both with high gross margins Major investments in the BioFarming platform and Intellectual property New patent application covers a 700% increase in Bioreactor production output Vancou...
20.01.2022BioHarvest Sciences Inc. Plans to Build a Production Facility in Ontario to Serve the Canadian Market with Unique Cannabis ProductsVancouver, British Columbia, and Rehovot, Israel--(Newsfile Corp. - January 20, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") has announced its plan to build a production facility in Canada...
06.01.2022BioHarvest Sciences Reports Double-Digit Q4 Sales Orders Growth in First Full Year of VINIA Sales17% quarter-over-quarter growth with record VINIA® global sales orders in Q4 of USD 825k 485% year-over-year growth with total sales orders of USD 2.4M in 2021 Continued success in VINIA® US pilot with USD 325k in sales orders in Q4, a 27% ...
30.12.2021BioHarvest Sciences Inc. 2021 CEO Letter to Shareholder PartnersVancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - December 30, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) (OTC PINK: CNVCF) ("BioHarvest" or the "Company") is pleased to provide the following year-end ...
08.12.2021BioHarvest Sciences Inc. Produces Significant Amount of Cannabis Without Growing the Cannabis PlantCannabis produced has a Trichomes density of up to 200 times greater than in a plant-grown product while solving major industry challenges of consistency, safety, and environmental sustainability The Company is ready to engage with key play...
22.11.2021BioHarvest Sciences New 20 Tons per Year Factory Obtains the GMP (Good Manufacturing Practices) Certification from the Israeli Ministry of HealthThe new factory is ready to start production to meet the increased demand for VINIA® On track for the conversion of the existing 2 tons/year facility to a Cannabis production facility within H1, 2022 Vancouver, British Columbia and Rehovot,...
15.11.2021New Research Analysis Shows VINIA Reduces Oxidation Of LDL-Cholesterol To Support Cardiovascular Improved FunctioningNew research analysis affirms the addition of the following structure function claims for VINIA® according to FDA Guidelines for Dietary Supplements: VINIA® prevents Lipid Oxidation VINIA® protects the body by preventing oxidative damage to...
27.10.2021BioHarvest Sciences Inc. Appoints Steven Lehrer to Its Board of AdvisorsSteven Lehrer's 40 years of Biotech experience enhances the board of advisors with expertise in pharmaceutical, biopharmaceutical, and biosimilar R&D. His appointment continues to demonstrate the Company's resolve to leverage its biotec...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In